Human tissue for human wounds

Minimal manipulation to maximize retained components

Our human placental tissue products, carefully processed to minimize manipulation of the native tissue, are composed of native cells, growth factors and an intact extracellular matrix:

  • Designed as wound covers for a wide variety of acute and chronic wounds in head-to-toe locations
  • Flexible, conforming cover that may be applied to complex anatomies and may be used over exposed bone, tendon, joint capsule, muscle and hardware
  • Two storage options are available:
    • GRAFIX PL Membrane is lyopreserved and stored at room temperature for off-the-shelf convenience
    • GRAFIXCryopreserved Placental Membrane is stored at -75°C to -85°C
31-GRAFIX-US-840x840.png

Product features

Medical Education

No results
No results

Reimbursement

For reimbursement and coverage information by state, click here.

Sizes and Ordering Information

Placental tissue sourceProduct descriptionPart #
Lyopreserved amniotic membraneGRAFIX PL XC 5 cm x 5 cm (25 cm2)PS15055
GRAFIX PL XC 7 cm x 7 cm (49 cm2)PS15077
GRAFIX PL XC 7.5 cm x 15 cm (113 cm2)PS15075
GRAFIX PL PRIME 1.5 cm x 2 cm (3 cm2)PS13015
GRAFIX PL PRIME 2 cm x 3 cm (6 cm2)PS13023
GRAFIX PL PRIME 3 cm x 3 cm (9 cm2)PS13033
GRAFIX PL PRIME 3 cm x 4 cm (12 cm2)PS13034
GRAFIX PL PRIME 5 cm x 5 cm (25 cm2)PS13055
Lyopreserved chorion membraneGRAFIX PLUS 2 x 3 cm (6 cm2)PS16023
GRAFIX PLUS 3 x 4 cm (12 cm2)PS16034
Cryopreserved amniotic membraneGRAFIX XC 7.5 cm x 15 cm (113 cm2)PS24075
GRAFIX PRIME 16 mm Disc (2 cm2)PS60013
GRAFIX PRIME 1.5 cm x 2 cm (3 cm2)PS11015
GRAFIX PRIME 2 cm x 3 cm (6 cm2)PS11023
GRAFIX PRIME 3 cm x 4 cm (12 cm2)PS11034
GRAFIX PRIME 5 cm x 5 cm (25 cm2)PS11055

Disclaimer

Always refer to the enclosed package insert for the complete application protocol. Smith+Nephew does not provide medical advice. The information presented is not, and is not intended to serve as, medical advice. For detailed information, including indications for use, contraindications, precautions and warnings, please consult the product’s package insert prior to use. It is the responsibility of healthcare professionals to determine and utilize the appropriate products and techniques according to their own clinical judgment for each of their patients.

Use of this Web site is governed by the Terms of Use, Copyright and Disclaimer and Privacy Policy. This website is intended for caregivers in the United States only. The information provided is for informational purposes only and is not intended to be medical advice. It does not replace the professional training, experience and knowledge of the healthcare provider responsible for patient care, who must base treatment upon the unique characteristics of each patient. Every patient’s case is unique and each patient should follow his or her doctor’s specific instructions. For detailed product information, including indications for use, contraindications, effects, precautions and warnings, please consult each product’s Instructions for Use (IFU) prior to use.

©2022 Smith+Nephew, Inc. All rights reserved.

Osiris, GRAFIX, GRAFIX PL, GRAFIX PRIME, GRAFIX CORE, GRAFIX PL XC, GRAFIX XC, and GRAFIX PL PRIME are trademarks of Osiris Therapeutics, Inc., a wholly owned direct subsidiary of Smith+Nephew Consolidated, Inc.
All Trademarks acknowledged.

GRAFIX Customer Care: T 1-888-674-9551 F 443-283-4419

Advanced Wound Management Smith+Nephew, Inc.

Recall and Complaints

Customer will provide such support and assistance as S+N may reasonably request in the event of a general or limited voluntary or mandatory recall of the Product(s). Customer shall promptly report any complaint in respect of the Products to complaints@smith-nephew.com.

Terms & Conditions and Warranties

Citations
  1. Dhall S, et al. Plos One. 2018; 13 (10): e0204060
  2. Rodríguez-Ares MT, et al. Acta Ophthalmol. 2009; 87 (4): 396-403
  3. Lim LS, et al. Arch Ophthalmol. 2010; 128 (10): 1303-1310
  4. Niknejad H, et al. Cryobiology. 2011; 63 (3): 145-151
  5. Thomasen H, et al. Graefes Arch Clin Exp Ophthalmol. 2009; 247 (12): 1691-1700
  6. Diabetic foot problems: prevention and management. National Institute for Health and Care Excellence (NICE) guideline. Published: 26 August 2015. https://www.nice.org.uk/guidance/ng19
  7. Diabetic foot problems: prevention and management. National Institute for Health and Care Excellence (NICE) guideline. Published: January 2016. https://www.nice.org.uk/guidance/ng19/evidence/appendix-h-data-analysis-435358773, page 11
  8. Diabetic foot problems: prevention and management. National Institute for Health and Care Excellence (NICE) guideline. Published: January 2016. https://www.nice.org.uk/guidance/ng19/evidence/appendix-i-grade-profiles-15672915540

Title

Text